Novavax, Inc. (NVAX)

Novavax Revenue

Novavax had revenue of $239.24M in the quarter ending June 30, 2025, a decrease of -42.42%. This brings the company's revenue in the last twelve months to $1.08B, up 9.22% year-over-year. In the year 2024, Novavax had annual revenue of $682.16M, down -30.65%.

• Revenue (ttm): $1.08B
• Revenue Growth: +9.22%
• P/S Ratio: 1.21
• Revenue / Employee: $1,133,107
• Employees: 952
• Market Cap: 1.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	682.16M	-301.54M	-30.65%
Dec 31, 2023	983.71M	-998.17M	-50.36%
Dec 31, 2022	1.98B	835.58M	72.89%
Dec 31, 2021	1.15B	670.69M	141.02%
Dec 31, 2020	475.60M	456.94M	2,448.48%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.